A role for phospholipase C-γ-mediated signaling in tumor cell invasion

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2251-2260

  Kassis, Jareer ^a   Moellinger, Jason ^a   Lo, Han ^a   Greenberg, Norman M ^b   Kim, Hyung Gyoon ^a   Wells, Alan ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; METASTASIS POTENTIAL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CELL LINE; DIFFUSION CHAMBERS, CULTURE; EPIDERMAL GROWTH FACTOR; ESTRENES; FEMALE; HUMANS; IMMUNOBLOTTING; ISOENZYMES; MALE; MICE; NEOPLASM INVASIVENESS; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PYRROLIDINONES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0032803235     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Landis, S., Murray, T., Bolden, S., and Wingo, P. Cancer Statistics 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Castellani, R., Visscher, D., Wykes, S., Sarkar, F., and Crissman, J. Interaction of transforming growth factor-α and epidermal growth factor receptor in breast carcinoma. An immunohistologic study. Cancer (Phila.), 73: 344-349, 1994.
3. Cohen, D., Simak, R., Fair, W., Melamed, J., Scher, H., and Cordon-Cardo, C. Expression of transforming growth factor-α and the epidermal growth factor receptor in human prostate tissues. J. Urol., 152: 2120-2124, 1994.
4. R) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. Carcinogenesis (Lond.), 17: 2571-2579, 1996.
5. Pilichowska, M., Kimura, N., Fujiwara, H., and Nagura, H. Immunohistological study of TGF-α, TGF-β1, EGFR, and IGF-1 expression in human breast carcinoma. Mod. Pathol., 10: 969-975, 1997.
6. Gao, X., Porter, A., Grignon, D. J., Pontes, J. E., and Honn, K. V. Diagnostic and prognostic markers for human prostate cancer. Prostate, 31: 264-281, 1997.
7. Klijn, J. G., Berns, P. M., Schmitz, P. I., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrine Rev., 13: 3-17, 1992.
8. Sainsbury, J. R. C., Farndon, J. R., Harris, A. L., and Sherbet, G. V. Epidermal growth factor receptors on human breast cancers. Br. J. Surg., 72: 186-188, 1985.
9. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
10. Chen, P., Gupta, K., and Wells, A. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol., 124: 547-555, 1994.
11. Chen, P., Xie, H., Sekar, M. C., Gupta, K. B., and Wells, A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but MAP kinase activity is not sufficient for induced cell movement. J. Cell Biol., 127: 847-857, 1994.
12. Stone, K., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU145). Int. J. Cancer, 21: 274-281, 1978.
13. Turner, T., Chen, P., Goodly, L. J., and Wells, A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis, 14: 409-418, 1996.
14. Turner, T., VanEpps-Fung, M., Kassis, J., and Wells, A. Molecular inhibition of PLCγ signaling abrogates DU-145 prostate tumor cell invasion. Clin. Cancer Res., 3: 2275-2282, 1997.
15. Xie, H., Turner, T., Wang, M-H., Singh, R. K., Siegal, G. P., and Wells. A. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis, 13: 407-419, 1995.
16. Burgess, W. H., Dionne, C. A., Kaplow, J., Mudd, R., Friesel, R., Zilberstein, A., Schlessinger, J., and Jaye, M. Characterization and cDNA cloning of phospholipase C-γ, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factorl-activated tyrosine kinase. Mol. Cell. Biol., 10: 4770-4777, 1990.
17. DiFiore, P. P., Segatto, O., Lonardo, F., Fazioli, F., Pierce, J. H., and Aaronson, S. A. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic tyrosine kinase function and transforming ability. Mol. Cell. Biol., 10: 2749-2756, 1990.
18. Margolis, B., Rhee, S., Felder, S., Mervic, M., Lyall, R., Levitzki, A., Ullrich, A., Zilberstein, A., and Schlessinger, J. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell, 57: 1101-1107, 1990.
19. Meisenhelder, J., Suh, P. G., Rhee, S. G., and Hunter, T. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell, 57: 1109-1122, 1989.
20. Wahl, M., Olashaw, N., Nishibe, S., Rhee, S., Pledger, W., and Carpenter, G. Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-γ in quiescent BALB/ c3T3 cells. Mol. Cell. Biol., 9: 2934-2943, 1989.
21. Bornfeldt, K. E., Raines, E. W., Nakano, T., Graves, L. M., Krebs, E. G., and Ross, R. Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest., 93: 1266-1274, 1994.
22. Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., and Zetter, B. R. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature (Lond.), 367: 474-476, 1994.
23. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, N. M. Metastatic prostate cancer in a transgenic mouse. Cancer Res., 56: 4096-4102, 1996.
24. Gingrich, J. R., and Greenberg, N. M. A transgenic mouse prostate cancer model. Toxicol. Pathol., 24: 502-504, 1996.
25. Saisbury, J. R. C., Farndon, J. R., Needham, G. K., Malcolm, A. J., and Harris, A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, i: 1398-1402, 1987.
26. Rios, M. A., Macias, A., Perez, R., Lage, A., and Skoog, L. Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res., 8: 173-176, 1988.
27. Wiltschke, C., Kindas-Muegge, I., Steininger, A., Reiner, A., Reiner, G., and Preis, P. N. Coexpression of Her-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients. J. Cancer Res. Clin. Oncol., 120: 737-742, 1994.
28. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
29. HER2/neu-overexpressing human tumor lines. J. Biol. Chem., 267: 4357-4363, 1992.
30. Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., and Yarden, Y. Isolation of the neu/HER-2 stimulatory ligand: a 44kd glycoprotein that induces differentiation of mammary tumor cells. Cell, 69: 205-216, 1992.
31. Reese, D. M., and Slamon, D. J. HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells, 15: 1-8, 1997.
32. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. SH2 domains recognize specific phosphopeptide sequences. Cell, 72: 767-778, 1993.
33. Yuhas, J., and Tarleton, A. Dormancy and spontaneous recurrence of human breast cancer in vitro. Cancer Res., 38: 3584-3589, 1978.
34. Mueller, S., Paterson, A., and Kudlow, J. Transforming growth factor a in arterioles: cell surface processing of its precursor by elastases. Mol. Cell. Biol., 10: 4596-4602, 1990.
35. Homma, Y., and Takenawa, T. Inhibitory effect of src homology (SH) 2/SH3 fragments of phospholipase C-γ on the catalytic activity of phospholipase C isoforms: identification of a novel phospholipase C inhibitor region. J. Biol. Chem., 267: 21844-21849, 1992.
36. Hendrix, M., Seftor, E., Seftor, R., and Fidler, I. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett., 38: 137-147, 1987.
37. Chu, Y., Runyan, R., Oshima, R., and Hendrix, M. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA, 90: 4261-4265, 1993.
38. Sekar, M. C., Dixon, J. F., and Hokin, L. E. The formation of inositol 1,2-cyclin 4,5-trisphosphate and inositol 1,2-cyclic 4 bisphosphate on stimulation of mouse pancreastic minilobules with carbamylcholine. J. Biol. Chem., 262: 340-344, 1987.
39. Sekar, M. C., Sambandam, V., and McDonald, J. M. Bombesin and muscarinic receptor activation in rat pancreas generate cyclic inositol monophosphate: possible involvement of different phospholipase isozymes. Biochem. Biophys. Res. Commun., 192: 1079-1085, 1993.
40. Soderquist, A. M., Todderud, G., and Carpenter, G. Elevated membrane association of phospholipase C-γ1 in MDA-468 mammary tumor cells. Cancer Res., 52: 4526-4529, 1995.
41. Church, J. G., Richardson, V. J., and Lockwood, A. G. Atypical receptor-mediated signal transduction events in the EGF-dependent growth-inhibited cell line, MDA-468. J. Cell. Physiol., 153: 373-380, 1992.
42. Qian, X., O'Rourke, D., Fei, Z., Zhang, H., Kao, C., and Greene, M. Domain-specific interaction between the p185neu and epidermal growth factor receptor kinases determine differential signaling outcomes. J. Biol. Chem., 274: 574-583, 1999.
43. Worthylake, R., and Wiley, H. Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J. Biol. Chem., 272: 8594-8601, 1997.
44. Riedel, H., Dull, T. J., Honegger, A. M., Schlessinger, J., and Ullrich, A. Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J., 8: 2943-2954, 1989.
45. Doherty, J., Lin, Y. J., Christianson, T. A., Holmes, R., Keenan, E. J., and Clinton, G. M. Truncated HER-2/neu cytoplasmic domain with enhanced kinase activity in human breast cancer. Proc. Am. Assoc. Cancer Res., 38: 173, 1997.
46. Bleasdale, J. E., Thakur, N. R., Gremban, R. S., Bundy, G. L., Fitzpatrick, F. A., Smith, R. J., and Bunting, S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Then, 255: 756-768, 1990.
47. Smith, R. J., Sam, L. M., Justen, J. M., Bundy, G. L., Bala, G. A., and Bleasdale, J. E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther., 253: 688-697, 1990.
48. Ji, Q-S., Ermini, S., Baulida, J., Sun, F-L., and Carpenter, G. Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol. Biol. Cell, 9: 749-757, 1998.
49. Fry, D. W., Kraker, A. J., McMicheal, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Conners, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 265: 1093-1095, 1994.
50. Geldof, A. A., and Rao, B. R. Factors in prostate cancer metastasis. Anticancer Res., 10: 1303-1306, 1990.
51. Linehan, W. M. Inhibition of prostate cancer metastasis: a critical challenge ahead. J. Natl. Cancer Inst., 87: 331-332, 1995.
52. Neal, D. E., Marsh, C., Bennett, M. K., Abel, P. D., Hall, R. R., Sainsbury, J. R. C., and Harris, A. L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet. i: 366-368, 1985.
53. Nguyen, P. L., Swanson, P. E., Jaszcz, W., Aeppli, D. M., Zhang, G., Singleton, T. P., Ward, S., Dykoski, D., Harvey, J., and Niehans, G. A. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am. J. Clin. Pathol., 101: 166-176, 1994.
54. Wells, A., Bishop, J. M., and Helmeste, D. Amplified gene for EGF receptor in a human glioblastoma cell line presenting an enzymatically inactive protein. Mol. Cell. Biol., 8: 4561-4565, 1988.
55. Chen, J. D., Kim, J. P., Zhang, K., Sarret, Y., Wynn, K. C., Kramer, R. H., and Woodley, D. T. Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the α2 integrin subunit. Exp. Cell Res., 209: 216-223, 1993.
56. ElYazidi, I., and Boilly-Marer, Y. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. Anticancer Res., 15: 783-790, 1995.
57. Osborne, C., Clemmons, D., and Arteaga, C. Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol., 37: 805-809, 1990.
58. Wiley, H. S. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system. J. Cell Biol., 107: 801-810, 1988.
59. Reddy, C. C., Wells, A., and Lauffenburger, D. A. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α. J. Cell. Physiol., 166: 512-522, 1996.
60. Siegal, G. P., Wang, M-H., Rinehart, C. A., Kennedy, J. W., Goodly, L. J., Miller, Y., Kaufman, D. G., and Singh, R. K. Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Lett., 69: 123-132, 1993.
61. Vukicevic, S., Kleinman, H. K., Luyten, F. P., Roberts, A. B., Roche, N. S., and Reddi, A. H. Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res., 202: 1-8, 1992.
62. Gailit, J., and Clark, R. A. F. Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol., 6: 717-725, 1994.
63. Fidler, I. Cancer metastasis (Review). Br. Med. Bull., 47: 157-177, 1991.
64. Woodhouse, E., Chuaqui, R., and Liotta, L. General mechanisms of metastasis (Review). Cancer (Phila.), 80: 1529-1537, 1997.
65. Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B., Kinzler, K. W., Paraskeva, C., Vogelstein, B., and Stanbridge, E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol., 12: 1387-1395, 1992.
66. Segall, J. E., Tyerech, S., Boselli, L., Masseling, S., Helft, J., Chan, A., Jones, J., and Condeelis, J. EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin. Exp. Metastasis, 14: 61-72, 1996.
67. Xie, H., Pallero, M. A., Gupta, D., Chang, P., Ware, M. F., Witke, W., Kwiatkowski, D. J., Lauffenburger, D. A., Murphy-Ullrich, J. E., and Wells, A. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway. J. Cell Sci., 111: 615-624, 1998.
68. Wells, A., Gupta, K., Chang, P., Swindle, S., Glading, A., and Shiraha, H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc. Res. Tech., 43: 395-411, 1998.
69. Gamett, D., Pearson, G., Cerione, R., and Friedberg, I. Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem., 272: 12052-12056, 1997.
70. Yoshida, K., Tsujino, T., Yasui, W., Kameda, T., Sano, T., Nakayama, H., Toge, T., and Tahara, E. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-α in human gastric carcinoma cell line MKN-28. Jpn. J. Cancer Res., 81: 793-798, 1990.
71. Zhang, R. D., Fidler, I. J., and Price, J. E. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis, 11: 204-215, 1991.